Goun Je, MD
Neurology · Atlanta
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · The Emory Clinic Inc · 3,507 clinicians in this group
Hospitals listed: Emory University Hospital · Emory University Hospital Midtown. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Je’s office at (404) 778-7525 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A176502 · Delinquent
Licence status: Delinquent · since 2022 · expires 2026-02-28 · Kyunghee University College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emory University HospitalAtlanta, GAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Emory Healthcare, which runs 9 hospitalsHome of Winship Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.42 (1.2 to 1.63), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.89 (4.29 to 7.5) · 3,224 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative hemorrhage or hematoma rate: 3.85 (2.74 to 4.96) · 2,977 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.571, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.382, Oct 2024 – Sep 2025
- Emory University Hospital MidtownAtlanta, GAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Emory Healthcare, which runs 9 hospitalsPatients rate it 2 of 5 · 69% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2 (1.08 to 2.91) · 1,256 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.397, Oct 2024 – Sep 2025
See every measure and the patient survey for Emory University Hospital
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.42 (1.2 to 1.63) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.89 (4.29 to 7.5) · 3,224 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.85 (2.74 to 4.96) · 2,977 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.571 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.382 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.56 (0.79 to 2.33) · 2,905 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 160.16 (123.83 to 196.49) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 369 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 331 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 526 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,498 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.38 (0.2 to 0.56) · 9,728 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.13 to 0.49) · 10,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.33 (1.09 to 3.57) · 1,664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.06 (9 to 17.13) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.04 (4.51 to 9.57) · 1,705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.54 (0.23 to 2.85) · 1,260 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.83 (0.4 to 1.26) · 8,918 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 94 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.111 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.947 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.726 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 182 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 911 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25.6 · 95 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.1 · 463 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.9 · 359 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 574 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.4 to 7.8) · 118 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.6 to 14.3) · 118 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 17.2) · 94 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 917 cases | No different | Jan 2024 – Dec 2024 |
What patients said (556 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Emory University Hospital Midtown
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 2 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2 (1.08 to 2.91) · 1,256 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.241 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.397 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.21 (0.95 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.95 (95.25 to 192.66) · 107 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 278 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.1 · 158 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.2 · 205 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 3,631 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 5,448 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.44) · 5,960 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.64 (1.75 to 5.52) · 2,075 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.22 (0.87 to 3.58) · 1,215 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.38 (2.15 to 4.61) · 1,969 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.29 (7.49 to 17.1) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.99 (3.15 to 8.83) · 1,241 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 472 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.75 (0.2 to 1.31) · 4,965 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 46 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.737 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.154 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.384 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 214 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 1,108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -13.1 · 69 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 43.4 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 151 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.9 · 472 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (4.2 to 6.2) · 1,558 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.1 (9.6 to 12.7) · 1,558 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 124 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 285 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.3) · 139 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 506 cases | No different | Jan 2024 – Dec 2024 |
What patients said (556 patients answered, 14% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$8,126
Medicare paid this office $8,126 for 49 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 26 | $3,357 | $120 |
| New patient visit (60+ min) | 15 | $2,060 | $137 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 30 | $1,588 | $24 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $180 | $13 |
Who their Medicare patients are
49 Original Medicare patients in 2024. Average age 75 · Women 53% · Health risk score 1.46. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 65% · Depression 33% · Dementia 31% · Chronic kidney disease 22%.
The office billed $43,909, Medicare allowed $10,608 and paid $8,126; for 136 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 49 | 136 | 75 | 1.46 | $43,909 | $8,126 |
| 2023 | 14 | 25 | 74 | 1.27 | $13,408 | $2,214 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$5,168
Pharmacies billed $5,168 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
112 generic and fewer than 11 brand-name prescriptions · $5,168 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa Er | 20 | $831 | $42 |
| Carbidopa-Levodopa | 27 | $715 | $26 |
| Escitalopram | 15 | $35 | $2 |
Year by year
| 2024 | 117 | 60 | None | None | $5,168 |
| 2023 | 276 | 68 | 0% (0) | 16% | $164,256 |
| 2022 | 235 | 48 | 0% (0) | 10% | $30,166 |
| 2021 | 304 | 46 | 0% (0) | 16% | $54,799 |
| 2020 | 394 | 49 | 0% (0) | 17% | $141,770 |
| 2019 | 169 | 54 | None | 20% | $25,356 |
| 2018 | 44 | 23 | None | None | $2,288 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Austedo | 23 | $122,905 | $5,344 |
| Rivastigmine | 18 | $9,300 | $517 |
| Carbidopa-Levodopa Er | 43 | $2,905 | $68 |
| Amantadine | 14 | $894 | $64 |
| Carbidopa-Levodopa | 33 | $871 | $26 |
| Lamotrigine | 29 | $487 | $17 |
| Donepezil | 17 | $348 | $20 |
| Quetiapine | 13 | $97 | $7 |
2022: 7 drugs
| Carbamazepine Er | 15 | $3,187 | $212 |
| Carbidopa-Levodopa Er | 19 | $1,842 | $97 |
| Divalproex | 16 | $818 | $51 |
| Lamotrigine | 43 | $659 | $15 |
| Gabapentin | 24 | $637 | $27 |
| Clobazam | 18 | $301 | $17 |
| Carbidopa-Levodopa | 13 | $271 | $21 |
2021: 11 drugs
| Vimpat | 29 | $26,878 | $927 |
| Carbamazepine Er | 17 | $3,492 | $205 |
| Divalproex | 29 | $2,909 | $100 |
| Levetiracetam | 24 | $1,015 | $42 |
| Gabapentin | 21 | $815 | $39 |
| Lamotrigine | 51 | $765 | $15 |
| Oxcarbazepine | 12 | $704 | $59 |
| Zonisamide | 14 | $682 | $49 |
| Topiramate | 22 | $414 | $19 |
| Clobazam | 13 | $277 | $21 |
| Amitriptyline | 13 | $90 | $7 |
2020: 10 drugs
| Vimpat | 39 | $31,684 | $812 |
| Carbamazepine Er | 17 | $6,209 | $365 |
| Clobazam | 19 | $4,421 | $233 |
| Levetiracetam | 36 | $1,862 | $52 |
| Divalproex | 27 | $1,683 | $62 |
| Zonisamide | 20 | $867 | $43 |
| Gabapentin | 16 | $650 | $41 |
| Lamotrigine | 41 | $599 | $15 |
| Topiramate | 27 | $424 | $16 |
| Atorvastatin | 31 | $316 | $10 |
2019: 1 drug
| Atorvastatin | 15 | $230 | $15 |
Money from drug and device companies
$20,139 in 2023
A payment is not proof that care is biased.
| Medtronic | Activa PC | $20,139 | 2 payments
|
See all 2 published payments
| Medtronic | Grant · 2023-10-25 | Activa PC | $20,000 |
| Medtronic | Meals · 2023-05-19 | Percept PC Brainsense | $139 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1245735877
- Licence
- CA A176502, GA 99619California A176502: Delinquent · expires 2026-02-28
- Group
- The Emory Clinic Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 12 Executive Park Dr Ne, Atlanta, GA, 30329
- NPI first listed
- 2018-03-26
- NPI last updated
- 2024-05-09
- NPI record certified
- 2024-05-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 213 Quarry Rd, Palo Alto, CA, 94304